Rena Therapeutics Inc.
PrivateLast Round
M&A
Nov 21, 2019
Est. Valuation
$16.62M
Total Funding Raised
$10.36M
Company Overview
Rena Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series B round in June 2017.
Rena Therapeutics Inc. is a biotechnology company that develops Heteroduplex Oligonucleotide (HDO) technology as a platform for nucleic acid medicine drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rena Therapeutics Inc. Comparables
Compare Rena Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liid Pharmaceuticals, Inc. | 81% | |
| Bonac Corporation | 73% | |
| NapaJen Pharma, Inc. | 72% |
For institutional investors. Book with your work email.
Rena Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 21, 2019 | ||||
| Series B | Jun 30, 2017 | ||||
| Series A | Apr 20, 2015 |
For institutional investors. Book with your work email.
Rena Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Network Corporation of Japan | Series A, Series B |
| DBJ Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Monthly visitors grew 38% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Rena Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rena Therapeutics Inc.'s valuation, stock price, and market status.
Is Rena Therapeutics Inc. a public or private company?
Rena Therapeutics Inc. is a private company.
What is the current stock price of Rena Therapeutics Inc.?
Rena Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Rena Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rena Therapeutics Inc. worth (valuation)?
Rena Therapeutics Inc.'s valuation is estimated at $16.6M based on funding round data.
Can I buy Rena Therapeutics Inc. stock?
Rena Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rena Therapeutics Inc.'s last funding round?
Rena Therapeutics Inc.'s most recent funding round was M&A on November 21, 2019.
Who are the main investors in Rena Therapeutics Inc.?
Key investors in Rena Therapeutics Inc. include Innovation Network Corporation of Japan, DBJ Capital.
Will Rena Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Rena Therapeutics Inc..
How can I track Rena Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Rena Therapeutics Inc.'s shares on secondary markets.